Literature DB >> 23470001

Nanostructured cubosomes as advanced drug delivery system.

Xin Pan1, Ke Han, Xinsheng Peng, Zhiwen Yang, Lingzhen Qin, Chune Zhu, Xintian Huang, Xuan Shi, Linghui Dian, Ming Lu, Chuanbin Wu.   

Abstract

Some kinds of amphiphilic lipids can spontaneously self-assemble with a proper ratio of water to form liquid crystalline, also known as cubic phase. With a curved bi-continuous lipid bilayer and two congruent networks of water channels, cubic phases can enclose hydrophilic, amphiphilic and hydrophobic drugs for delivery. Nanostructured cubosomes, prepared by fragmentation of bulk cubic phase gels or lyotropic methods, retain the same inner structure of cubic phase and possess much larger specific surface area and lower viscosity. These unique properties make cubosomes excellent delivery systems applicable for oral, mucosal, transdermal and parenteral drug delivery. This article gave an overview of the accelerated development and current status of cubosomes research, with respect to their preparation, characteristics and applications in pharmaceutics.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23470001     DOI: 10.2174/1381612811319350006

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  18 in total

Review 1.  Liquid Crystalline Phases for Enhancement of Oral Bioavailability.

Authors:  Xingwang Zhang; Wei Wu
Journal:  AAPS PharmSciTech       Date:  2021-02-22       Impact factor: 3.246

2.  Phytantriol Based "Stealth" Lyotropic Liquid Crystalline Nanoparticles for Improved Antitumor Efficacy and Reduced Toxicity of Docetaxel.

Authors:  Sanyog Jain; Neha Bhankur; Nitin K Swarnakar; Kaushik Thanki
Journal:  Pharm Res       Date:  2015-05-13       Impact factor: 4.200

3.  Nanosized Cubosomal Thermogelling Dispersion Loaded with Saquinavir Mesylate to Improve Its Bioavailability: Preparation, Optimization, in vitro and in vivo Evaluation.

Authors:  Khaled M Hosny
Journal:  Int J Nanomedicine       Date:  2020-07-16

4.  Cubosomes for Enhancing Intestinal Absorption of Fexofenadine Hydrochloride: In situ and in vivo Investigation.

Authors:  Amal A Sultan; Nourhan F El Nashar; Shimaa M Ashmawy; Gamal M El Maghraby
Journal:  Int J Nanomedicine       Date:  2022-08-10

Review 5.  A Versatile Nanocarrier-Cubosomes, Characterization, and Applications.

Authors:  Cristiana Oliveira; Celso J O Ferreira; Miguel Sousa; Juan L Paris; Ricardo Gaspar; Bruno F B Silva; José A Teixeira; Pedro Ferreira-Santos; Claudia M Botelho
Journal:  Nanomaterials (Basel)       Date:  2022-06-29       Impact factor: 5.719

6.  Microfluidics Synthesis of Gene Silencing Cubosomes.

Authors:  Hojun Kim; Jaeuk Sung; Yunju Chang; Alana Alfeche; Cecilia Leal
Journal:  ACS Nano       Date:  2018-08-15       Impact factor: 15.881

7.  Anticancer Activity of Thymoquinone Cubic Phase Nanoparticles Against Human Breast Cancer: Formulation, Cytotoxicity and Subcellular Localization.

Authors:  Mohammed M Mehanna; Rana Sarieddine; Jana K Alwattar; Racha Chouaib; Hala Gali-Muhtasib
Journal:  Int J Nanomedicine       Date:  2020-12-01

8.  Etodolac transdermal cubosomes for the treatment of rheumatoid arthritis: ex vivo permeation and in vivo pharmacokinetic studies.

Authors:  Salwa Salah; Azza A Mahmoud; Amany O Kamel
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

9.  An injectable in situ gel with cubic and hexagonal nanostructures for local treatment of chronic periodontitis.

Authors:  Liling Mei; Xintian Huang; Yecheng Xie; Jintian Chen; Ying Huang; Bei Wang; Hui Wang; Xin Pan; Chuanbin Wu
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

10.  AT101-Loaded Cubosomes as an Alternative for Improved Glioblastoma Therapy.

Authors:  Dorota K Flak; Vivian Adamski; Grzegorz Nowaczyk; Kosma Szutkowski; Michael Synowitz; Stefan Jurga; Janka Held-Feindt
Journal:  Int J Nanomedicine       Date:  2020-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.